Quinn Mallery (@QMalleryMD) header
Quinn Mallery (@QMalleryMD) profile picture

Loyola Cardiology Fellow 🫀Wisconsin #Badgers alumni 🦡

Chicago, IL
Joined August 2023
Photo by Quinn Mallery (@QMalleryMD)Photo by Quinn Mallery (@QMalleryMD)
Quinn Mallery retweeted
Need to do better for #PE risk stratification, beyond reductionist models. In an @ESC_Journals #EHJ paper we show that a multimarker calculator🌡️outperforms the ESC model. Great work by @DJC6998 @mmonrealriete et al #RIETE! Honored to be a part of it 👇: tinyurl.com/trpmzbrd
1
31
93
5,255
Quinn Mallery retweeted
From the latest issue: Newman and colleagues analyze the @PERTConsortium database to demonstrate sex-based differences in the evaluation and management of patients with acute pulmonary embolism. buff.ly/3Bu61jV #PulmonaryEmbolism @EricSecemskyMD @krosenfieldMD
3
10
869
MI care pathways should implement early combination therapy with statins and #ezetimibe as standard care, because delaying use of combination LLT or using high-intensity statin monotherapy is associated with avoidable harm. jacc.org/doi/10.1016/j.jacc.… #JACC #cvMI #SWEDEHEART
23
2
47
8,008
Meta-analysis of 6 major randomized intravenous iron trials in heart failure in @NatureMedicine nature.com/articles/s41591-0… @ShahzebKhanMD
1
4
7
476
Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency - The FAIR-HF2 DZHK05 Randomized Clinical Trial Late-breaker @ACCinTouch and simultaneously published in @JAMA_current jamanetwork.com/journals/jam…
3
20
51
5,258
We are excited to share our perspective on building a multidisciplinary Amyloidosis program from the ground up. Challenges and ways we overcame them. Thank you @ACCinTouch for the platform to share our story @TJUHospital @CU_Cardiology acc.org/Latest-in-Cardiology…
3
20
2
70
6,037
Halting the progression of #ATTR amyloidosis with a single infusion. Loved to hear about the promising Phase 1 results at #AHA24—looking forward to updates from future trials!
Presented at #AHA24: A phase 1 trial of nexiguran ziclumeran (nex-z) to treat transthyretin cardiomyopathy showed a rapid and durable reduction of 90% in serum transthyretin levels and evidence of disease stabilization. Full trial results: nej.md/48OTgx4
1
281
Great day at #AHA24 attending some excellent presentations by @LoyolaHealth residents!
2
121
Quinn Mallery retweeted
1/ Published today, the Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery 📷: Stepwise Approach to Perioperative Cardiac Assessment.
2
302
19
677
202,815
Exciting future ahead for PE trials! Great talk by @darki_amir Looking forward especially to the results of PE-TRACT and learning how catheter-directed interventions can impact longer term functional outcomes #PERT2024
4
249
Quinn Mallery, an internal medicine resident (!!!) looking at RV dysfunction and PE severity. Excellent talk by a rising star in #PE research. #PERT2024 Bring your #PE studies here!!!
1
1
7
2,520
Awesome video showing a percutaneous thrombectomy performed at @LoyolaHealth Looking forward to #PERT24!
Shout out to our Loyola PERT team @JacobAClarke @QMalleryMD @DSutherlandMD helping make our video highlighting the impactful lessons we learned in past PERT consortium meetings. If you have an interest in PE, this is the one meeting you need to be at. @LUcardsfellows @YevgeniyBr @PERTConsortium pertconsortium.org/
2
283
The @LoyolaHealth team is gearing up for #PERT2024, and they’re sharing why you should be there too! From groundbreaking research to life-saving innovations, discover why this Is a must-attend event: pertconsortium.org/pert-annu…
4
7
516
Quinn Mallery retweeted
Enjoyed presenting at #SCAI2024 this weekend. We had a great showing from Loyola with presentations also from @jjlop131, @QMalleryMD, and @emilyjanak1 👏👏
4
7
1,102
Quinn Mallery retweeted
Enjoying a great conference at SCAI with @QMalleryMD @emilyjanak1
2
4
336